Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The dawn of a cure for sickle cell disease through CRISPR‐based treatment: A critical test of equity in public health genomics

22 Mar 2024

Abstract excerpt

Equity in access to genomic technologies, resources, and products remains a great challenge. This was evident especially during the coronavirus disease 2019 (COVID-19) pandemic when the majority of lower middle-income countries were unable to achieve at least 10% population vaccination coverage during initial COVID-19 vaccine rollouts, despite the rapid development of those vaccines. Sickle cell disease (SCD) is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Hemoglobinopathies and Related Disorders
Share to Iron Metabolism and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38517013
DOI: 10.1111/ahg.12558

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The dawn of a cure for sickle cell disease through CRISPR‐based treatment: A critical test of equity in public health genomicsPMID 38517013Read ↗

The future of sickle cell disease therapeutics rests in genomicsSemantic proximity Read ↗

Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell diseaseSemantic proximity Read ↗

Towards affordable CRISPR genomic therapies: a task force convened by the Innovative Genomics InstituteSemantic proximity Read ↗

CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and ApplicationsSemantic proximity Read ↗

A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem CellsSemantic proximity Read ↗

Advances in Gene Therapy for Sickle Cell Disease: From Preclinical Innovations to Clinical Implementation and Access ChallengesSemantic proximity Read ↗

The Italian breakthrough in CRISPR trials for rare diseases: a focus on beta-thalassemia and sickle cell disease treatmentSemantic proximity Read ↗

Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive CrisesSemantic proximity Read ↗

Sickle Cell Trait—Neglected Opportunities in the Era of Genomic MedicineSemantic proximity Read ↗

The Cas9 Hammer-and Sickle: A Challenge for Genome Editors.Semantic proximity Read ↗

Exagamglogene Autotemcel: First Approval.Semantic proximity Read ↗

Comparative Meta-Analysis of Four Breakthrough Medical Innovations (2015–2025): CRISPR, mRNA Vaccines, AI Diagnostics, and TelemedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.